Download Quicktime version of this video (.mov, 320x240, 165 MB)
(You must be logged in with a free vimeo.com account to download the video. Sign up is quick and easy.)

Download audio-only version of this session (.mp3, 2 hours, 25 MB)

Confronting the “Evidence” in Evidence-Based HIV Prevention: Challenges and Opportunities

A panel discussion at the National HIV Prevention Conference, Atlanta, GA on December 3, 2007

This session explored current debates and dilemmas in defining, advancing, and re-prioritizing evidence-based HIV prevention.  A panel of scientists, policy-makers, practitioners, and funders will discussed how evidence is gleaned and interpreted from biomedical, behavioral, and social interventions, and how this informs decisions about which HIV prevention interventions to implement and scale-up.  Key topics covered included:

• What kinds of evidence can and should be used to determine whether HIV prevention programs and interventions really work?
• What are the implications of evidence emerging from recent clinical trials of biomedical technologies—particularly those that have produced negative results or that have been prematurely stopped—for setting priorities in HIV prevention?

Welcome and Introductions: Mark Cloutier, MPP, MPH,
Executive Director 
San Francisco AIDS Foundation

Moderator: Judy Auerbach, Ph.D.,
Deputy Executive Director for Science and Public Policy
San Francisco AIDS Foundation

Panelists:

Bart Aoki, Ph.D., Associate Director
California HIV/AIDS Research Program

Kevin Cranston, MDiv, Director, HIV/AIDS Bureau 
Massachusetts Department of Public Health

Rafael Diaz, Ph.D., Director, Cesar Chavez Institute
San Francisco State University

Carl Dieffenbach, Ph.D., Acting Director, Division of AIDS
National Institute of Allergy and Infectious Diseases, NIH

Nancy Padian, Ph.D.,
Executive Director, Women’s Global Health Imperative
University of California at San Francisco

Comments: Michael Bartos, BA, M.Ed.
Chief, Prevention, Care and Support 
UNAIDS Secretariat


Presented by the San Francisco AIDS Foundation and Caucus for Evidence-Based Prevention in partnership with amfAR, The Foundation for AIDS Research The AIDS Institute (TAI) The AIDS Vaccine Advocacy Coalition (AVAC) Community HIV/AIDS Mobilization Project (CHAMP) National Minority AIDS Council (NMAC) The Sexuality Information and Education Council of the United States (SIECUS) Nancy Padian, Ph.D., Executive Director, Women’s Global Health Imperative University of California at San Francisco